HSBC Holdings
DAWN

HSBC Holdings’s Day One Biopharmaceuticals DAWN Stock Holding History

HSBC Holdings’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-49,333
Closed -$455K – 2979
2025
Q4 		$455K Sell
49,333
-60,448
-55% -$505K ﹤0.01% 2364
2025
Q3 		$772K Sell
109,781
-21,887
-17% -$151K ﹤0.01% 1903
2025
Q2 		$846K Buy
131,668
+81,491
+162% +$561K ﹤0.01% 1883
2025
Q1 		$383K Buy
50,177
+11,594
+30% +$125K ﹤0.01% 2224
2024
Q4 		$481K Buy
+38,583
New +$537K ﹤0.01% 2203
2024
Q3 		– Sell
-11,658
Closed -$163K – 3017
2024
Q2 		$163K Buy
+11,658
New +$171K ﹤0.01% 2627

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

HSBC Holdings's DAWN Position: Q1 2026 in Review

HSBC Holdings sold out of Day One Biopharmaceuticals (DAWN) in Q1 2026, closing a stake of 49,333 shares — an estimated $455K sold.

HSBC Holdings first reported a position in DAWN in Q2 2024 and held it in 6 quarters. The position peaked at $846K in Q2 2025. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • HSBC Holdings reported no remaining Day One Biopharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • HSBC Holdings sold 49,333 Day One Biopharmaceuticals shares in Q1 2026, an estimated $455K.
  • HSBC Holdings first reported a position in Day One Biopharmaceuticals in Q2 2024 and held it in 6 quarters.
  • HSBC Holdings's Day One Biopharmaceuticals position peaked at $846K in Q2 2025.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.